Literature DB >> 26539664

Cross-sectional and longitudinal growth patterns in osteogenesis imperfecta: implications for clinical care.

Emily L Germain-Lee1,2, Feng-Shu Brennen1, Diana Stern1, Aditi Kantipuly1, Pamela Melvin1, Mia S Terkowitz1, Jay R Shapiro1,3.   

Abstract

BACKGROUND: There is strikingly limited information on linear growth and weight in the different types of osteogenesis imperfecta (OI). Here, we define growth patterns further with the intent of implementing appropriate adaptations proactively.
METHODS: We report cross-sectional anthropometric data for 343 subjects with different OI types (144 children, 199 adults). Longitudinal height data for 36 children (18 girls, 18 boys) with OI type I and 10 children (8 girls, 2 boys) with OI type III were obtained.
RESULTS: In all cases, the height Z-scores were negatively impacted, and final height Z-scores were impacted the most. In type I, the growth velocities taper near puberty, and there is a blunted pubertal growth spurt. The growth velocities of children with type III decelerate before age 5 y; poor growth continues without an obvious pubertal growth spurt. Obesity is a concern for all patients with OI, with type III patients being the most affected.
CONCLUSION: The linear growth patterns, in addition to the marked increase in weight over time, indicate a need for lifestyle modifications early in childhood, especially a need for weight control. Further definition of the anthropometric measures in OI enables patients to begin modifications as early as possible.

Entities:  

Mesh:

Year:  2015        PMID: 26539664     DOI: 10.1038/pr.2015.230

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  32 in total

1.  Impact of alendronate on quality of life in children with osteogenesis imperfecta.

Authors:  Mouin G Seikaly; Sashi Kopanati; Nina Salhab; Pamela Waber; Diane Patterson; Richard Browne; John A Herring
Journal:  J Pediatr Orthop       Date:  2005 Nov-Dec       Impact factor: 2.324

2.  Osteogenesis imperfecta type III. Delineation of the phenotype with reference to genetic heterogeneity.

Authors:  D O Sillence; K K Barlow; W G Cole; S Dietrich; A P Garber; D L Rimoin
Journal:  Am J Med Genet       Date:  1986-03

3.  Osteogenesis imperfecta, current and future medical treatment.

Authors:  Frank Rauch; Francis H Glorieux
Journal:  Am J Med Genet C Semin Med Genet       Date:  2005-11-15       Impact factor: 3.908

4.  Controlled trial of pamidronate in children with types III and IV osteogenesis imperfecta confirms vertebral gains but not short-term functional improvement.

Authors:  Anne D Letocha; Holly L Cintas; James F Troendle; James C Reynolds; Christopher E Cann; Edith J Chernoff; Suvimol C Hill; Lynn H Gerber; Joan C Marini
Journal:  J Bone Miner Res       Date:  2005-01-18       Impact factor: 6.741

5.  Muscle strength, joint range of motion, and gait in children and adolescents with osteogenesis imperfecta.

Authors:  Evelise Brizola; Ana Lúcia Portella Staub; Têmis Maria Félix
Journal:  Pediatr Phys Ther       Date:  2014       Impact factor: 3.049

6.  Do patients with osteogenesis imperfecta need individualized nutritional support?

Authors:  Carlos Eduardo Andrade Chagas; Janaína Pivetta Roque; Bárbara Santarosa Emo Peters; Marise Lazaretti-Castro; Lígia Araújo Martini
Journal:  Nutrition       Date:  2011-07-27       Impact factor: 4.008

7.  Osteogenesis imperfecta: a clinical study of the first ten years of life.

Authors:  U Vetter; B Pontz; E Zauner; R E Brenner; J Spranger
Journal:  Calcif Tissue Int       Date:  1992-01       Impact factor: 4.333

8.  Skeletal effects and functional outcome with olpadronate in children with osteogenesis imperfecta: a 2-year randomised placebo-controlled study.

Authors:  Ralph Sakkers; Dieke Kok; Raoul Engelbert; Alice van Dongen; Maarten Jansen; Hans Pruijs; Ab Verbout; Dave Schweitzer; Cuno Uiterwaal
Journal:  Lancet       Date:  2004-05-01       Impact factor: 79.321

Review 9.  Osteogenesis imperfecta.

Authors:  Francis H Glorieux
Journal:  Best Pract Res Clin Rheumatol       Date:  2008-03       Impact factor: 4.098

10.  Genotype-phenotype correlations in autosomal dominant osteogenesis imperfecta.

Authors:  I Mouna Ben Amor; Francis H Glorieux; Frank Rauch
Journal:  J Osteoporos       Date:  2011-09-06
View more
  9 in total

1.  Hearing loss in individuals with osteogenesis imperfecta in North America: Results from a multicenter study.

Authors:  Keren Machol; Trevor D Hadley; Jake Schmidt; David Cuthbertson; Henri Traboulsi; Rodrigo C Silva; Chloe Citron; Sobiah Khan; Kate Citron; Erin Carter; Kenneth Brookler; Jay R Shapiro; Robert D Steiner; Peter H Byers; Francis H Glorieux; Michaela Durigova; Peter Smith; Michael B Bober; Vernon R Sutton; Brendan H Lee; Sandesh C S Nagamani; Cathleen Raggio
Journal:  Am J Med Genet A       Date:  2019-12-26       Impact factor: 2.802

2.  Mobility in osteogenesis imperfecta: a multicenter North American study.

Authors:  Karen M Kruger; Angela Caudill; Mercedes Rodriguez Celin; Sandesh C S Nagamani; Jay R Shapiro; Robert D Steiner; Michael B Bober; Tracy Hart; David Cuthbertson; Jeff Krischer; Peter H Byers; Michaela Durigova; Francis H Glorieux; Frank Rauch; V Reid Sutton; Brendan Lee; Eric T Rush; Peter A Smith; Gerald F Harris
Journal:  Genet Med       Date:  2019-03-28       Impact factor: 8.822

3.  Developmental charts for children with osteogenesis imperfecta, type I (body height, body weight and BMI).

Authors:  Krzysztof Graff; Malgorzata Syczewska
Journal:  Eur J Pediatr       Date:  2017-01-05       Impact factor: 3.183

Review 4.  Osteogenesis Imperfecta: New Perspectives From Clinical and Translational Research.

Authors:  Josephine T Tauer; Marie-Eve Robinson; Frank Rauch
Journal:  JBMR Plus       Date:  2019-02-20

5.  Functional Independence of Taiwanese Children with Osteogenesis Imperfecta.

Authors:  Yu-Min Syu; Chung-Lin Lee; Chih-Kuang Chuang; Huei-Ching Chiu; Ya-Hui Chang; Hsiang-Yu Lin; Shuan-Pei Lin
Journal:  J Pers Med       Date:  2022-07-24

6.  The role of osteocalcin in regulation of glycolipid metabolism and muscle function in children with osteogenesis imperfecta.

Authors:  Wen-Bin Zheng; Jing Hu; Di-Chen Zhao; Bing-Na Zhou; Ou Wang; Yan Jiang; Wei-Bo Xia; Xiao-Ping Xing; Mei Li
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-02       Impact factor: 6.055

7.  Anthropometrics of Polish children with osteogenesis imperfecta: a single-centre retrospective cohort study.

Authors:  E Jakubowska-Pietkiewicz; A Maćkowska; J Nowicki; E Woźniak; Nowicki Jakub
Journal:  BMC Pediatr       Date:  2022-10-06       Impact factor: 2.567

8.  A Multicenter Study of Intramedullary Rodding in Osteogenesis Imperfecta.

Authors:  Mercedes Rodriguez Celin; Karen M Kruger; Angela Caudill; Sandesh C S Nagamani; Gerald F Harris; Peter A Smith
Journal:  JB JS Open Access       Date:  2020-09-11

9.  Postural balance, handgrip strength and mobility in Brazilian children and adolescents with osteogenesis imperfecta.

Authors:  Giovana Coêlho; Lívia Cocato Luiz; Luiz Claudio Castro; Ana C de David
Journal:  J Pediatr (Rio J)       Date:  2020-06-08       Impact factor: 2.990

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.